基本的な属性 物理性質 安全性情報 GHS 用途語 上流と下流の製品情報 キーワード

モルヒネ 化学構造式

モルヒネ

化学名:モルヒネ

CAS番号.57-27-2

英語名:MORPHINE

CBNumberCB0680482

MFC17H19NO3

MW285.34

MOL File57-27-2.mol

别名

4,5α-エポキシ-17-メチル-7,8-ジデヒドロモルフィナン-3,6α-ジオール

モルヒネ

(9α,13α,14α)-7,8-ジデヒドロ-4,5β-エポキシ-17-メチルモルフィナン-3,6β-ジオール

(5S,9α,13α,14α)-7,8-ジデヒドロ-4,5β-エポキシ-17-メチルモルフィナン-3,6β-ジオール

(+)-モルフィン

モルフィウム

7,8-ジデヒドロ-4,5α-エポキシ-17-メチルモルフィナン-3,6α-ジオール

(-)-モルフィン

モルフィナ

17-メチル-7,8-ジデヒドロ-4,5α-エポキシモルフィナン-3,6α-ジオール

(-)-モルヒネ

モルフィン

(5R,6S)-7,8-ジデヒドロ-4,5-エポキシ-17-メチルモルフィナン-3,6-ジオール

N-メチルナロルフィン

モルフィア

(1R,5S,13S,14R,17S)-4-メチル-12-オキサ-4-アザペンタシクロ[9.6.1.01,13.05,17.07,18]オクタデカ-7,9,11(18),15-テトラエン-10,14-ジオール

more

モルヒネ物理性質

融点  255°C
沸点  427.77°C (rough estimate)
比重(密度)  1.0864 (rough estimate)
屈折率  1.5400 (estimate)
闪点  11 °C
貯蔵温度  −20°C
溶解性 Ethanol (Slightly), Methanol (Slightly)
外見  Solid
酸解離定数(Pka) 8.21(at 25℃)
White to Pale Yellow
水溶解度  0.4mg/L(25℃)
BCS Class 1,3
CAS データベース 57-27-2
EPAの化学物質情報 Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5.alpha.,6.alpha.)- (57-27-2)

安全性情報

主な危険性  F,T
Rフレーズ  11-23/24/25-39/23/24/25
Sフレーズ  7-16-36/37-45
RIDADR  UN 1230 3/PG 2
WGK Germany  2
有毒物質データの 57-27-2(Hazardous Substances Data)
毒性 An alkaloid of the opium poppy that makes up between 9% and 14% of good grades of opium. Morphine is usually used clinically as an analgesic in the form of the sulfate or hydrochloride salt. The most important acute toxic effect of large doses of morphine is depression of the respiratory centers in the medulla and pons. Morphine and related drugs also cause somnolence, coma, cold clammy skin, bradycardia, and hypotension. Initial doses of morphine seem to stimulate the chemoreceptor trigger zone to induce emesis, with subsequent doses blocking the vomiting center, hence blocking emesis. Morphine also has profound effects on the gastrointestinal tract, increasing the tone of the intestinal tract, but decreasing the propulsive or spasmodic reflexes, thus resulting in constipation. Morphine stimulates the nucleus of the third cranial nerve to produce miosis, making pinpoint pupil a diagnostic sign both in morphine overdose and morphine addiction. Morphine causes a variety of effects on the CNS and is highly addictive. Many behavioral changes are seen, ranging from euphoria to sedation. These behavioral effects contribute to the problem of abuse with all of the opiates. Tolerance and dependence occur with repeated dosing, with increasingly larger doses being needed to obtain the original effect. Abrupt withdrawal after chronic use can lead to physiological rebound in these same systems. Therapy for acute overdosage involves physiological support (establishment of adequate respiratory exchange), gastric lavage, and use of narcotic antagonists. Morphine and related compounds act by binding to specific high-affinity receptors concentrated in the nervous system, but also located elsewhere in the body. In the nervous system, the endogenous ligands for these morphine receptors are the opioid peptides that include the enkephalins, endorphins, and dynorphins. The multiple and complex actions of morphine are due, in part, to the fact that it acts as an agonist at many of these classes of receptors. Paregoric (camphorated tincture of opium) is used as an antidiarrheal. Paregoric is a schedule III drug under the US Controlled Substances Act and may produce physical dependence.

危険有害性情報のコード(GHS)

モルヒネ 化学特性,用途語,生産方法